Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 The renal adverse effect of PM 2.5 and NO2 after adjusting medication usage in diabetic kidney disease patients
저자 Soie Kwon
출판정보 2023; 2023(1):
키워드
초록 Objectives: There is increasing evidence that air pollutants adversely affect renal function in chronic kidney disease. Also, exposure to air pollution increases the incidence of type 2 diabetes and insulin resistance. Although, the evaluation of the air pollution effect in diabetic kidney disease (DKD) patients is insufficient. Moreover, the effect of medications that mainly affect the prognosis was not properly accessed. We investigated the effect of air pollutants in DKD patients with detailed adjustment of medication usage. Methods: This retrospective cohort study enrolled DKD patients from two South Korean tertiary-referral centers. A primary outcome was an incident event of end-stage kidney disease (ESKD). We collected national-wide monthly information on four air pollutants (PM2.5, PM10, NO2, and CO) from 2000 to 2020. Prescription information of oral anti-diabetic drugs (metformin, sulfonylurea [SU], and DPP-4 inhibitors), insulin, and renin-angiotensin system inhibitor were collected from each hospital. A multivariable time-dependent Cox analysis was conducted, and the air pollutants and medication usage were considered as time-varying variables. Results: Among 10,010 patients, a total of 1,884 patients (18.8%) progressed to ESRD during a median follow-up period of 98 months [interquartile range, 48; 157]. During the follow-up, the prescription ratio of metformin and DPP-4 inhibitors increased continuously. Whereas, the proportion of SU and insulin were constants over time (Figure 1). In univariate analysis, the increment of PM 2.5 was associated with an increased risk of incident ESKD (hazard ratio [HR] 1.04, 95% confidence interval [CI] 1.019―1.052). After adjustment of baseline characteristics and time-varying medication usage, the increased PM 2.5 (adjusted HR [aHR] 1.02, 95% CI 1.009―1.041) and NO2 (aHR 1.02, 95% CI 1.004―1.028, Table 1) concentration were associated with increased risk of ESKD. Conclusions: In the present study, there was evidence of adverse effects related to exposure to PM2.5 and NO2 in ESKDprogression even aftercomprehensive adjustmentof medication.
원문(PDF) PDF 원문보기
위로가기